SCTX · Scribe Therapeutics, Inc. · Shareholders & Ownership
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of SCTX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns SCTX
13F quarter Sep 30, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 80,825 | 0.43% |
| Insiders (Forms 3, 4, 5) | 11,564,242 | 61.08% |
| 13D/G-only blocks | 1,802,178 | 9.52% |
| Remaining | 5,484,435 | 28.97% |
| Registered funds (N-PORT, not summed) | 509,872 | 2.69% |
Shares outstanding: 18,931,680, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of SCTX
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
3,088,888 | ||
| 2 |
|
3,082,725 | ||
| 3 |
Avoro Capital Advisors LLC
13D
CIK 1633313 · Registered investment adviser · Jul 24, 2026
Item 4 purpose: Passive investment
not summed
|
2,598,973 | ||
| 4 |
RA CAPITAL MANAGEMENT, L.P.
13G
CIK 1346824 · Registered investment adviser · Jul 27, 2026
Rule 13d-1(c), passive investor
|
1,802,178 | ||
| 5 |
|
1,388,161 | ||
| 5.1 |
|
1,054,828 | ||
| 6 |
|
1,348,825 | ||
| 7 |
ORBIMED ADVISORS LLC
13D
CIK 1055951 · Registered investment adviser · Jul 27, 2026
Item 4 purpose: Passive investment
not summed
|
1,348,825 | ||
| 7.1 |
|
1,348,825 | ||
| 8 |
|
603,547 | ||
| 9 |
|
524,336 | ||
| 10 |
|
506,602 | ||
| 11 |
ARK Genomic Revolution ETF
Fund
S000042975 · Registered fund · Jul 31, 2026
ARK ETF Trust, not summed
|
352,097 | ||
| 12 |
Franklin Biotechnology Discovery Fund
Fund
S000006882 · Registered fund · Jul 31, 2026
Franklin Strategic Series, not summed
|
135,567 | ||
| 13 |
Sumitomo Mitsui Trust Group, Inc.
13F
CIK 1475365 · Bank · Sep 30, 2026
|
74,910 | ||
| 14 |
Fidelity Nasdaq Composite Index Fund
Fund
S000055366 · Registered fund · Aug 31, 2026
Fidelity Concord Street Trust, not summed
|
19,247 | ||
| 15 |
Tema ETFs LLC
13F
CIK 2056807 · Registered investment adviser · Sep 30, 2026
|
3,046 | ||
| 16 |
|
3,000 | ||
| 17 |
|
2,666 | ||
| 18 |
STRS OHIO
13F
CIK 820478 · Pension or benefit plan · Sep 30, 2026
|
2,600 | ||
| 19 |
Tema Healthcare AI ETF
Fund
S000104207 · Registered fund · Aug 31, 2026
Tema ETF Trust, not summed
|
1,836 | ||
| 20 |
VANGUARD RUSSELL 2000 INDEX FUND
Fund
S000030003 · Registered fund · Aug 31, 2026
VANGUARD SCOTTSDALE FUNDS, not summed
|
500 | ||
| 21 |
BlackRock Advantage Small Cap Core Fund
Fund
S000039982 · Registered fund · Aug 31, 2026
BlackRock Funds, not summed
|
487 | ||
| 22 |
Sterling Capital Management LLC
13F
CIK 1329883 · Registered investment adviser · Sep 30, 2026
|
269 | ||
| 23 |
Strategic Advisers U.S. Total Stock Fund
Fund
S000084926 · Registered fund · Aug 31, 2026
Fidelity Rutland Square Trust II, not summed
|
138 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.